Arrowhead Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. 

CEO
Christopher Richard Anzalone
CEOChristopher Richard Anzalone
Employees
711
Employees711
Headquarters
Pasadena, California
HeadquartersPasadena, California
Founded
1989
Founded1989
Employees
711
Employees711

ARWR Key Statistics

Market cap
9.46B
Market cap9.46B
Price-Earnings ratio
-1,035.57
Price-Earnings ratio-1,035.57
Dividend yield
Dividend yield
Average volume
2.50M
Average volume2.50M
High today
$71.14
High today$71.14
Low today
$68.17
Low today$68.17
Open price
$68.95
Open price$68.95
Volume
2.67M
Volume2.67M
52 Week high
$76.76
52 Week high$76.76
52 Week low
$9.57
52 Week low$9.57

Stock Snapshot

Arrowhead Pharmaceuticals(ARWR) stock is priced at $69.49, giving the company a market capitalization of 9.46B. It carries a P/E multiple of -1035.57.

On 2026-01-22, Arrowhead Pharmaceuticals(ARWR) stock moved within a range of $68.17 to $71.14. With shares now at $69.49, the stock is trading +1.9% above its intraday low and -2.3% below the session's peak.

Trading volume for Arrowhead Pharmaceuticals(ARWR) stock has reached 2.67M, versus its average volume of 2.5M.

Over the past 52 weeks, Arrowhead Pharmaceuticals(ARWR) stock has traded between a high of $76.76 and a low of $9.57.

Over the past 52 weeks, Arrowhead Pharmaceuticals(ARWR) stock has traded between a high of $76.76 and a low of $9.57.

ARWR News

Simply Wall St 7h
Is Arrowhead Pharmaceuticals Fairly Priced After Strong 1 Year Share Price Surge?

If you are wondering whether Arrowhead Pharmaceuticals' current share price offers good value, this article will walk through what the numbers are saying about...

Is Arrowhead Pharmaceuticals Fairly Priced After Strong 1 Year Share Price Surge?

Analyst ratings

64%

of 14 ratings
Buy
64.3%
Hold
28.6%
Sell
7.1%

People also own

Based on the portfolios of people who own ARWR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 companies by market cap and showing a subset from that 100.

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.